drugset / Trial / NCT00601289

Temozolomide in Treating Patients With Invasive Pituitary Tumors

NCT00601289 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well temozolomide works in treating patients with invasive pituitary tumors.

Timeline

Start
2009-12
Primary completion
2010-10
Completion
—

Outcome

Outcome not reported

Stopped (Business): “funding term ended”

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule — Oral